Novello, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 191
EU - Europa 125
AS - Asia 53
AF - Africa 3
SA - Sud America 1
Totale 373
Nazione #
US - Stati Uniti d'America 190
CN - Cina 26
IE - Irlanda 26
FR - Francia 24
SE - Svezia 24
IT - Italia 15
SG - Singapore 14
DE - Germania 10
RU - Federazione Russa 8
FI - Finlandia 7
HK - Hong Kong 6
GB - Regno Unito 3
NL - Olanda 3
KG - Kirghizistan 2
LY - Libia 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
JP - Giappone 1
MA - Marocco 1
RO - Romania 1
UA - Ucraina 1
Totale 373
Città #
Dublin 26
Ashburn 25
Chandler 25
Beijing 15
Jacksonville 12
Lawrence 8
Princeton 8
Sindelfingen 8
Singapore 7
Helsinki 6
Washington 6
Wilmington 5
Hong Kong 4
Kent 4
Seattle 4
Verona 4
San Francisco 3
Amsterdam 2
Arzignano 2
Bishkek 2
Como 2
Liberty 2
Messina 2
Mountain View 2
New York 2
Parma 2
Southend 2
Baku 1
Boardman 1
Buenos Aires 1
Central 1
Hangzhou 1
Hebei 1
Houston 1
Irving 1
Jinan 1
Lamezia Terme 1
Lappeenranta 1
Los Angeles 1
Milan 1
Paris 1
Prague 1
Stockholm 1
Tokyo 1
Toronto 1
Vienna 1
Totale 209
Nome #
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 41
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study 38
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status 33
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 32
Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors 31
Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM) 29
Management of Italian patients with advanced non-small-cell lung cancer after second-line treatment: results of the longitudinal phase of the LIFE observational study 27
Nutritional support in lung cancer: Time to combine immunonutrition with immunotherapy? 26
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences 21
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 19
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling 18
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey 16
Drive the oncologists into exercise promotion in lung cancer 15
Exploring the role of respiratory microbiome in lung cancer: A systematic review 14
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients 12
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis 11
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients 10
Totale 393
Categoria #
all - tutte 2.644
article - articoli 2.644
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 1 0 0 0 0 1 0 0 0 0 0 1
2020/202118 0 0 0 1 5 5 0 0 0 0 7 0
2021/202239 1 5 0 4 0 0 4 1 1 1 4 18
2022/2023140 8 9 19 16 10 28 2 8 20 0 19 1
2023/2024181 7 14 23 20 21 19 13 14 1 5 32 12
2024/202512 12 0 0 0 0 0 0 0 0 0 0 0
Totale 393